Position in COGT
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$423
New position
Shares Held
11
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Whipplewood Advisors, LLC holds $18,301 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4 | $3,711 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
141 | $3,567 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
22 | $2,696 | |
| 4 | ABVX |
Abivax S.A.
|
19 | $2,531 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5 | $2,483 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
11 | $1,221 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
15 | $1,189 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3 | $903 |
All Filings in COGT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $423 | 11 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||